Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Avanos Medical ( (AVNS) ) is now available.
On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its new Chief Executive Officer, effective April 14, 2025. Pacitti, who previously held leadership roles at Siemens Healthineers and Abbott Vascular, brings extensive industry expertise and a strategic vision to the company. His appointment is expected to drive Avanos’s next phase of growth and success, with a focus on delivering breakthrough medical device solutions and enhancing long-term value for stakeholders.
More about Avanos Medical
Avanos Medical (NYSE: AVNS) is a medical technology company headquartered in Alpharetta, Georgia. The company focuses on delivering clinically superior medical device solutions aimed at improving patient quality of life, including providing nutrition support from hospital to home and reducing opioid use during recovery. Avanos develops, manufactures, and markets its products globally, holding leading market positions in various product categories.
YTD Price Performance: -8.65%
Average Trading Volume: 523,744
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $665.2M
Learn more about AVNS stock on TipRanks’ Stock Analysis page.